Medicine-specific information
Each article lists available products to help inform an intrathecal administration risk assessment
Anaesthesia and Pain
- Morphine: informing intrathecal risk assessment
- Phenol: informing intrathecal risk assessment
- Ropivacaine: informing intrathecal risk assessment
- Lidocaine: informing intrathecal risk assessment
- Diamorphine hydrochloride: informing intrathecal risk assessment
- Hydromorphone: informing intrathecal risk assessment
- Bupivacaine: informing intrathecal risk assessment
- Levobupivacaine: informing intrathecal risk assessment
- Ziconotide: informing intrathecal risk assessment
- Clonidine: informing intrathecal risk assessment
Cancers
- Hydrocortisone: informing intrathecal risk assessment
- Methotrexate: informing intrathecal risk assessment
- Etoposide: informing intrathecal risk assessment
- Rituximab: informing intrathecal risk assessment
- Topotecan: informing intrathecal risk assessment
- Hydrocortisone acetate: informing intrathecal risk assessment
- Cytarabine: informing intrathecal risk assessment
- Trastuzumab: informing intrathecal risk assessment
- Thiotepa: informing intrathecal risk assessment
Infection and infectious diseases
- Gentamicin: informing intrathecal risk assessment
- Colistimethate sodium: informing intrathecal risk assessment
- Fluorescein: informing intrathecal risk assessment
- Vancomycin: informing intrathecal risk assessment
- Amikacin: informing intrathecal risk assessment